115 related articles for article (PubMed ID: 10935472)
21. Effects of p51/p63 missense mutations on transcriptional activities of p53 downstream gene promoters.
Kato S; Shimada A; Osada M; Ikawa S; Obinata M; Nakagawara A; Kanamaru R; Ishioka C
Cancer Res; 1999 Dec; 59(23):5908-11. PubMed ID: 10606233
[TBL] [Abstract][Full Text] [Related]
22. Identification of a novel retrovirus long terminal repeat (LTR) that is targeted by p51A (TAp63gamma) and selective dominant-negative activity of p73L (DeltaNp63alpha) toward p53-responsive promoter activities.
Senoo M; Matsumura Y; Habu S
Biochem Biophys Res Commun; 2001 Aug; 286(3):628-34. PubMed ID: 11511106
[TBL] [Abstract][Full Text] [Related]
23. p51/p63, a novel p53 homologue, potentiates p53 activity and is a human cancer gene therapy candidate.
Kunisaki R; Ikawa S; Maeda T; Nakazaki Y; Kurita R; Harata M; Shutoh Y; Bai YS; Soda Y; Tanabe T; Dohi T; Kato R; Ikawa Y; Asano S; Tani K
J Gene Med; 2006 Sep; 8(9):1121-30. PubMed ID: 16832836
[TBL] [Abstract][Full Text] [Related]
24. AIS is an oncogene amplified in squamous cell carcinoma.
Hibi K; Trink B; Patturajan M; Westra WH; Caballero OL; Hill DE; Ratovitski EA; Jen J; Sidransky D
Proc Natl Acad Sci U S A; 2000 May; 97(10):5462-7. PubMed ID: 10805802
[TBL] [Abstract][Full Text] [Related]
25. A comparison of genomic structures and expression patterns of two closely related flanking genes in a critical lung cancer region at 3p21.3.
Timmer T; Terpstra P; van den Berg A; Veldhuis PM; Ter Elst A; Voutsinas G; Hulsbeek MM; Draaijers TG; Looman MW; Kok K; Naylor SL; Buys CH
Eur J Hum Genet; 1999; 7(4):478-86. PubMed ID: 10352938
[TBL] [Abstract][Full Text] [Related]
26. The transcriptional activities of p53 and its homologue p51/p63: similarities and differences.
Shimada A; Kato S; Enjo K; Osada M; Ikawa Y; Kohno K; Obinata M; Kanamaru R; Ikawa S; Ishioka C
Cancer Res; 1999 Jun; 59(12):2781-6. PubMed ID: 10383130
[TBL] [Abstract][Full Text] [Related]
27. High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?
Crook T; Nicholls JM; Brooks L; O'Nions J; Allday MJ
Oncogene; 2000 Jul; 19(30):3439-44. PubMed ID: 10918601
[TBL] [Abstract][Full Text] [Related]
28. Molecular characterization and expression of p63 isoforms in human keloids.
De Felice B; Wilson RR; Nacca M; Ciarmiello LF; Pinelli C
Mol Genet Genomics; 2004 Aug; 272(1):28-34. PubMed ID: 15248062
[TBL] [Abstract][Full Text] [Related]
29. TSG101 is not mutated in lung cancer but a shortened transcript is frequently expressed in small cell lung cancer.
Oh Y; Proctor ML; Fan YH; Su LK; Hong WK; Fong KM; Sekido YS; Gazdar AF; Minna JD; Mao L
Oncogene; 1998 Sep; 17(9):1141-8. PubMed ID: 9764824
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of the wild type p73 gene in human bladder cancer.
Yokomizo A; Mai M; Tindall DJ; Cheng L; Bostwick DG; Naito S; Smith DI; Liu W
Oncogene; 1999 Feb; 18(8):1629-33. PubMed ID: 10102633
[TBL] [Abstract][Full Text] [Related]
31. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
[TBL] [Abstract][Full Text] [Related]
32. Activation of p73 silent allele in lung cancer.
Mai M; Yokomizo A; Qian C; Yang P; Tindall DJ; Smith DI; Liu W
Cancer Res; 1998 Jun; 58(11):2347-9. PubMed ID: 9622072
[TBL] [Abstract][Full Text] [Related]
33. Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues.
Muttray AF; Cox RL; Reinisch CL; Baldwin SA
Mar Biotechnol (NY); 2007; 9(2):217-30. PubMed ID: 17242983
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of p53, p63 and p73 protein and mRNA for DMBA-induced hamster buccal-pouch squamous-cell carcinomas.
Chen YK; Huse SS; Lin LM
Int J Exp Pathol; 2004 Apr; 85(2):97-104. PubMed ID: 15154915
[TBL] [Abstract][Full Text] [Related]
35. p51/p63 Controls subunit alpha3 of the major epidermis integrin anchoring the stem cells to the niche.
Kurata S; Okuyama T; Osada M; Watanabe T; Tomimori Y; Sato S; Iwai A; Tsuji T; Ikawa Y; Katoh I
J Biol Chem; 2004 Nov; 279(48):50069-77. PubMed ID: 15361520
[TBL] [Abstract][Full Text] [Related]
36. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
[TBL] [Abstract][Full Text] [Related]
37. Infrequent mutations of the activating transcription factor-2 gene in human lung cancer, neuroblastoma and breast cancer.
Woo IS; Kohno T; Inoue K; Ishii S; Yokota J
Int J Oncol; 2002 Mar; 20(3):527-31. PubMed ID: 11836564
[TBL] [Abstract][Full Text] [Related]
38. Distinct expression patterns of the p53-homologue p73 in malignant and normal hematopoiesis assessed by a novel real-time reverse transcription-polymerase chain reaction assay and protein analysis.
Peters UR; Tschan MP; Kreuzer KA; Baskaynak G; Lass U; Tobler A; Fey MF; Schmidt CA
Cancer Res; 1999 Sep; 59(17):4233-6. PubMed ID: 10485463
[TBL] [Abstract][Full Text] [Related]
39. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.
Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M
Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030
[TBL] [Abstract][Full Text] [Related]
40. Frequent alteration of p63 expression in human primary bladder carcinomas.
Park BJ; Lee SJ; Kim JI; Lee SJ; Lee CH; Chang SG; Park JH; Chi SG
Cancer Res; 2000 Jul; 60(13):3370-4. PubMed ID: 10910040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
